Thursday, December 5, 2013
Publication and contact
Assays & screens
In vitro screening for genetic signatures associated with
sensitivity to targeted cancer therapeutics
Combined genetic and
chemical screening of lung cancer cells for altered genetic signatures could
reveal sensitivity to therapeutic candidates. The screening approach involved
identifying small molecule inhibitors and small interfering RNAs that reduced
growth of cancer cells from a patient tumor sample but had no effect on
growth of normal cells from the same patient. The small molecules and siRNAs
were then tested in a panel of 91 non-small cell lung cancer (NSCLC) cell
lines to identify common signatures of sensitivity. K-Ras (KRAS) and serine/threonine kinase 11
(STK11; LKB1) mutations
correlated with sensitivity to knockdown of constitutive photomorphogenic 1
(COP1; RFWD2). In addition, a
seven-gene expression signature correlated with sensitivity to an indolotriazine-based
compound. Next steps could include using this approach to identify
sensitivity to therapeutics in additional cancer types.
Published online Dec. 5, 2013
Patent and licensing status
Kim, H.S. et al. Cell;
published online Oct. 24, 2013;
Contact: Michael A. White, The University of Texas
Southwestern Medical Center, Dallas, Texas
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]